In this study, we confirmed previous reports that ESCC patients with higher numbers of CD8+ TILs within either tumor epithelium or tumor stroma had a better prognosis than those with a lower number of CD8+ TILs [6, 7]. This evidence concerns the gene CD8A and neoplasm.